Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peptide Identification Using Tandem Mass Spectrometry01:33

Peptide Identification Using Tandem Mass Spectrometry

8.8K
Tandem mass spectrometry, also known as MS/MS or MS2, is an analytical technique that employs two mass analyzers. Essentially it is a series of mass spectrometers that helps isolate a particular biomolecule and then helps study its chemical properties.
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...
8.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

USP22 deficiency in melanoma mediates resistance to T cells through IFNγ-JAK1-STAT1 signal axis.

Molecular therapy : the journal of the American Society of Gene Therapy·2021
Same author

Prognostic value of eight immune gene signatures in pancreatic cancer patients.

BMC medical genomics·2021
Same author

PPD: A Manually Curated Database for Experimentally Verified Prokaryotic Promoters.

Journal of molecular biology·2021
Same author

Generation of an induced pluripotent stem cell line from a Chinese Han infant with floating-harbor syndrome accompanied with dilated cardiomyopathy.

Stem cell research·2021
Same author

Identification of Key Histone Modifications and Their Regulatory Regions on Gene Expression Level Changes in Chronic Myelogenous Leukemia.

Frontiers in cell and developmental biology·2021
Same author

DM3Loc: multi-label mRNA subcellular localization prediction and analysis based on multi-head self-attention mechanism.

Nucleic acids research·2021
Same journal

Retraction: Long noncoding RNA XIST is a prognostic factor in colorectal cancer and inhibits 5-fluorouracil-induced cell cytotoxicity through promoting thymidylate synthase expression.

Oncotarget·2026
Same journal

TRAIL-R2 in the shadows: Epigenetic silencing and clinical implications in breast cancer.

Oncotarget·2026
Same journal

Retraction: MALAT1 predicts poor survival in osteosarcoma patients and promotes cell metastasis through associating with EZH2.

Oncotarget·2026
Same journal

Laryngeal leiomyosarcoma: A rare case report and literature review.

Oncotarget·2026
Same journal

Correction: Postsurgery fluids promote transition of cancer stem cell toendothelial and AKT/mTOR activity contributing to relapse of giant cell tumors of bone.

Oncotarget·2026
Same journal

DHHC3 interferes with antitumor immunity in melanoma cells.

Oncotarget·2026
See all related articles

Related Experiment Video

Updated: Mar 24, 2026

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology
08:27

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology

Published on: March 24, 2015

15.4K

iACP: a sequence-based tool for identifying anticancer peptides.

Wei Chen1,2, Hui Ding3, Pengmian Feng4

  • 1Department of Physics, School of Sciences, Center for Genomics and Computational Biology, North China University of Science and Technology, Tangshan, China.

Oncotarget
|March 5, 2016
PubMed
Summary
This summary is machine-generated.

Identifying anticancer peptides (ACPs) is crucial for new cancer therapies. A new computational tool, iACP, accurately predicts ACPs using sequence data, offering a faster alternative to traditional methods.

Keywords:
PseAACanticancer peptidesg-gap dipeptide modeiACP webserverincremental feature selection

More Related Videos

Peptide-based Identification of Functional Motifs and their Binding Partners
14:28

Peptide-based Identification of Functional Motifs and their Binding Partners

Published on: June 30, 2013

13.1K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.6K

Related Experiment Videos

Last Updated: Mar 24, 2026

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology
08:27

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology

Published on: March 24, 2015

15.4K
Peptide-based Identification of Functional Motifs and their Binding Partners
14:28

Peptide-based Identification of Functional Motifs and their Binding Partners

Published on: June 30, 2013

13.1K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.6K

Area of Science:

  • Biochemistry
  • Computational Biology
  • Oncology

Background:

  • Cancer is a leading global health concern, with conventional treatments causing significant side effects.
  • Anticancer peptides (ACPs) offer a promising alternative therapeutic strategy.
  • The rapid increase in peptide sequence data necessitates efficient computational identification of ACPs.

Purpose of the Study:

  • To develop a robust computational method for identifying anticancer peptides (ACPs).
  • To enhance the speed and accuracy of ACP discovery for potential cancer treatment applications.

Main Methods:

  • Development of a sequence-based predictor named iACP.
  • Optimization of the predictor using g-gap dipeptide components.
  • Rigorous validation through cross-validation techniques.

Main Results:

  • The iACP predictor demonstrated superior performance compared to existing methods.
  • Achieved high accuracy and stability in identifying anticancer peptides.
  • The predictor effectively utilizes sequence information for ACP identification.

Conclusions:

  • iACP provides a reliable and efficient computational tool for identifying anticancer peptides.
  • This method accelerates the discovery and application of ACPs in cancer therapy.
  • A publicly accessible web server is available for researchers to utilize iACP.